Kang, Hyoung Jin
Seoul National University · Seoul National University Children's Hospital
3 papers on CoChatORCID 0000-0003-1009-6002
Most cited papers
- Verified
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
Geoerger, B., Kang, H. J., Yalon-Oren, M., Marshall, L. V., Vezina, C., Pappo, A., Laetsch, T. W., Petrilli, A. S., Ebinger, M., Toporski, J., et al. (2020) · The Lancet Oncology
Cancer Immunotherapy and BiomarkersCutaneous Melanoma Detection and Management
Cited by 357
- Verified
Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine‐Docetaxel Chemotherapy
Lee, J. A., Jeon, D., Cho, W. H., Song, W. S., Yoon, H. S., Park, H. J., Park, B. K., Choi, H. S., Ahn, H. S., Lee, J. W., et al. (2016) · Pediatric Blood & Cancer
Sarcoma Diagnosis and TreatmentBone Tumor Diagnosis and Treatments
Cited by 21
- Verified
Avelumab in paediatric patients with refractory or relapsed solid tumours: dose-escalation results from an open-label, single-arm, phase 1/2 trial
Loeb, D. M., Lee, J. W., Morgenstern, D. A., Samson, Y., Uyttebroeck, A., Lyu, C. J., Van Damme, A., Nysom, K., Macy, M. E., Zorzi, A. P., et al. (2022) · Cancer Immunology Immunotherapy
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free